Ketamine followed by memantine for the treatment of major depression [1]

Australian and New Zealand Journal of Psychiatry

Volumn 42, Issue 2, 2008, Pages 170-

  Kollmar, Rainer ^a   Markovic, Katrin ^a   Thürauf, Norbert ^a   Schmitt, Hubert ^a   Kornhuber, Johannes ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DULOXETINE; KETAMINE; LAMOTRIGINE; LORAZEPAM; MEMANTINE; MIRTAZAPINE; OLANZAPINE; VENLAFAXINE;

ADULT; BECK DEPRESSION INVENTORY; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TREATMENT FAILURE; ELECTROCONVULSIVE THERAPY; FEMALE; HAMILTON SCALE; HUMAN; LETTER; MAJOR DEPRESSION; SUICIDE; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; DEPRESSIVE DISORDER, MAJOR; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KETAMINE; MEMANTINE; MIDDLE AGED; RECEPTORS, N-METHYL-D-ASPARTATE; TREATMENT OUTCOME;

EID: 38349123803     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670701787628     Document Type: Letter

References (3)

1. Zarate Jr, CA, Singh, JB and Carlson, PJ (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry, 63, pp. 856-864.
2. Zarate Jr, CA, Singh, JB and Quiroz, JA (2006) A double-blind, placebo-controlled study of memantine in the treatment of major depression. Am J Psychiatry, 163, pp. 153-155.
3. Kornhuber, J., Kennepohl, EM and Bleich, S. (2007) Memantine pharmacotherapy: A naturalistic study using a population pharmacokinetic approach. Clin Pharmacokinet, 46, pp. 599-612.